Patients with indolent lymphomas are at high risk of infections: experience from a German outpatient clinic

Abstract Background Patients with indolent B-cell non-Hodgkin lymphomas (B-NHLs) have an increased risk of infections which is caused by pathomechanisms of the diseases itself but also as a result of anti-tumor therapy. Especially the effects of anti-CD20 antibodies are well understood as these lead...

Full description

Bibliographic Details
Main Authors: Christoph Lutz, Stefan Feiten, Geothy Chakupurakal, Jochen Heymanns, Jörg Thomalla, Christoph van Roye, Rudolf Weide
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Immunology
Subjects:
Online Access:https://doi.org/10.1186/s12865-022-00536-x